Submit Deal

ATAI LIFE SCIENCES

Summary

ATAI Life Sciences operates as a biotech company. The company offers therapeutics, medicines, and drugs, as well as focuses on longevity and mental wellbeing. ATAI Life Sciences serves customers worldwide.

Deals Overview

Total Deals6

Valued Deals6

Total Value£ 391 M

Avg. Deal Size£ 65 M

Market Context

Senior Management

Florian Brand
CEO
Greg Weaver
CFO
Christian Angermayer
Founder and Chairman

Sort

27 Apr 2020|United Kingdom|Health Care Services

Target: COMPASS PATHWAYS

Bidder: CAMDEN PARTNERS NEXUS

7 Service Providers

1 Target | 6 Bidder

7 Dealmakers

1 Target | 6 Bidder

£ 64 M

Value

23 Nov 2020|Germany|Biotechnology

Target: ATAI LIFE SCIENCES

Bidder: CATALIO CAPITAL MANAGEMENT

11 Service Providers

4 Target | 7 Bidder

22 Dealmakers

13 Target | 9 Bidder

£ 93 M

Value

03 Mar 2021|Germany|Biotechnology

Target: ATAI LIFE SCIENCES

Bidder: THIEL CAPITAL

5 Service Providers

2 Target | 3 Bidder

6 Dealmakers

3 Target | 3 Bidder

£ 113 M

Value

12 May 2021|Canada|Pharmaceuticals

Target: INTELGENX TECHNOLOGIES CORP

Bidder: ATAI LIFE SCIENCES

4 Service Providers

2 Target | 2 Bidder

9 Dealmakers

3 Target | 6 Bidder

£ 8 M

Value

07 Dec 2023|United States|Medical Services

Target: CORTEX

Bidder: ATAI LIFE SCIENCES

7 Service Providers

1 Target | 5 Bidder | 1 Vendor

6 Dealmakers

1 Target | 5 Bidder | 1 Vendor

£ 71 M

Value

04 Jan 2024|United Kingdom|Biotechnology

Target: BECKLEY PSYTECH

Bidder: ATAI LIFE SCIENCES

3 Service Providers

1 Target | 2 Bidder

7 Dealmakers

2 Target | 5 Bidder

£ 39 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy